R-flurbiprofen improves tau, but not Aß pathology in a triple transgenic model of Alzheimer's disease.
about
Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways.SCM-198 inhibits microglial overactivation and attenuates Aβ(1-40)-induced cognitive impairments in rats via JNK and NF-кB pathways.4'-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation.Untangling the Web: Toxic and Protective Effects of Neuroinflammation and PGE2 Signaling in Alzheimer's Disease.In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals.Involvement of inflammation in Alzheimer's disease pathogenesis and therapeutic potential of anti-inflammatory agents.A state of delirium: Deciphering the effect of inflammation on tau pathology in Alzheimer's disease.The effects of aging, housing and ibuprofen treatment on brain neurochemistry in a triple transgene Alzheimer's disease mouse model using magnetic resonance spectroscopy and imaging.Targeting Neuroinflammation to Treat Alzheimer's Disease.Enantioseparation of Racemic Flurbiprofen by Aqueous Two-Phase Extraction With Binary Chiral Selectors of L-dioctyl Tartrate and L-tryptophan.Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice.Royal Jelly Attenuates LPS-Induced Inflammation in BV-2 Microglial Cells through Modulating NF-κB and p38/JNK Signaling Pathways.Suppression of Presymptomatic Oxidative Stress and Inflammation in Neurodegeneration by Grape-Derived Polyphenols
P2860
Q33825472-3B71F00E-048B-4796-B729-B33ED836C7C0Q34145823-E4DA4405-AD62-4DDC-8A62-7ABBD47016F2Q35814389-3C695A2A-479D-4D9E-ACD3-9918969E7FCAQ37588183-CFB3B1D0-88CC-4146-A5FA-1E45EE08F487Q38195938-B1CE9AB8-1197-4FCF-962A-82A8C04517BDQ38569669-F091C4ED-FC21-4A17-96FC-A1B3465D678AQ39039980-7D3CEE8A-994D-4688-8E46-D77F86BBB65DQ43077710-D914D6EC-2EC2-4C3B-9F58-1B28FCAC556CQ47188911-0B22752F-3D4D-4DFC-BB81-C7D8581A0521Q53181887-F83D9337-89CA-4AAC-A102-401AFE26FA7AQ53402722-E70CAED2-8CC4-4946-BAC2-BC9357E8B85EQ55154521-A71340E0-BEB8-4207-A742-36CF1AA06748Q58697995-CF9D717E-C5D3-47D0-A23E-7EE163D20665
P2860
R-flurbiprofen improves tau, but not Aß pathology in a triple transgenic model of Alzheimer's disease.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
R-flurbiprofen improves tau, b ...... model of Alzheimer's disease.
@ast
R-flurbiprofen improves tau, b ...... model of Alzheimer's disease.
@en
type
label
R-flurbiprofen improves tau, b ...... model of Alzheimer's disease.
@ast
R-flurbiprofen improves tau, b ...... model of Alzheimer's disease.
@en
prefLabel
R-flurbiprofen improves tau, b ...... model of Alzheimer's disease.
@ast
R-flurbiprofen improves tau, b ...... model of Alzheimer's disease.
@en
P2093
P2860
P1433
P1476
R-flurbiprofen improves tau, b ...... model of Alzheimer's disease.
@en
P2093
Alpaslan Dedeoglu
Ann C McKee
Bruce G Jenkins
Isabel Carreras
Ji-Kyung Choi
Neil W Kowall
Nurgul Aytan
P2860
P304
P356
10.1016/J.BRAINRES.2013.10.025
P407
P577
2013-10-22T00:00:00Z